Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations [Phase 2]
BEBT-109 is being studied in non-small cell lung cancer with EGFR exon 20 insertion mutations in a Phase 2 trial, which is currently not yet…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection [Phase 2]
Phase 2 clinical trial update for non-small cell lung cancer involving Pancoast tumors and chest wall involvement, evaluating radiation, imm…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies [Phase 2]
Phase 2 trial update for Zirconium-89 labeled Crefmirlimab Berdoxam PET/CT in advanced or metastatic cancers; the study is currently active …
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer [NA]
A clinical trial is evaluating pulsed electric field therapy for late-stage non-small cell lung cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: MYLUNG Consortium Part 3: Observational Study
This document reports a recruiting observational study in the MYLUNG Consortium Part 3 focusing on non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Low Volume High Intensity Interval Training in Operated Lung Cancer Patients [NA]
A clinical trial is evaluating the effects of low-volume high-intensity interval training in operated lung cancer patients, including non-sm…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
An ongoing clinical study is investigating therapeutic resistance and clonal evolution in non-small cell lung cancer patients treated with i…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. [Phase 1]
Phase 1 trial update for YE-NEO-001, NantBioScience's personalized neoepitope yeast vaccine, evaluating adjuvant immunotherapy to elicit T-c…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
This is a recruiting clinical study evaluating tumor tissue and blood-based approaches to guide personalized treatments for patients with su…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC [Phase 3]
Phase 3 clinical trial comparing MB12 to pembrolizumab (Keytruda) in stage IV non-small cell lung cancer is currently recruiting to evaluate…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
A clinical trial update investigating whether prodigiosin or pioglitazone can modulate the tumor immune microenvironment and its crosstalk w…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Study of Crizotinib for ROS1 and MET Activated Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating crizotinib for ROS1-rearranged and MET-activated non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
This is a prospective study to validate blood-based biomarkers associated with differences in the efficacy of neoadjuvant therapy for non-sm…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer. [NA]
This clinical trial update describes the assessment of invasive mediastinal staging in patients with cN1 non-small cell lung cancer. The stu…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence
This completed study reviews the use and findings of low-dose CT lung cancer screening within a high-incidence community healthcare system.
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients
This clinical trial registration describes a study of immunotherapy in first-line PD-L1-negative advanced non-small cell lung cancer and ind…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant intra-tumor double immunotherapy for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC [Phase 2]
This entry notes a Phase 2 neoadjuvant immunotherapy trial for localized non-small cell lung cancer with an EGFR activating mutation, curren…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC [Phase 1, Phase 2]
An ongoing Phase Ib/II trial is evaluating GH21 capsules in combination with osimertinib for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants [Phase 1]
Phase 1 study to evaluate how food and the proton pump inhibitor esomeprazole affect BAY2927088 blood levels in healthy participants.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study [Phase 3]
Phase 3 investigator-initiated randomized trial in EGFR-mutated non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC [Phase 3]
A Phase 3 prospective cohort study is evaluating neoadjuvant chemotherapy plus Sintillumab for resectable non-small cell lung cancer. The tr…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients [NA]
A clinical trial update for NCT04222335 sponsored by University Hospital, Toulouse, currently recruiting to study early adaptive resistance …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
This clinical trial is investigating real-world outcomes of non-small cell lung cancer patients treated with neoadjuvant immunotherapy, aimi…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC
This clinical trial investigates single-cell biomarkers to predict efficacy and toxicity of immune checkpoint inhibitors in non-small cell l…